These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 3877822
1. [Postoperative cell-mediated immunity in gastric cancer patients--with special reference to the effects of immunotherapy]. Sekizuka H, Noro K, Haruyama S, Kiribuchi Y, Hayashi F. Gan No Rinsho; 1985 Sep; 31(11):1381-6. PubMed ID: 3877822 [Abstract] [Full Text] [Related]
2. [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy]. Saito H, Kikkawa H, Bando H, Sakatoku M, Hirano M, Tatsuzawa T. Gan No Rinsho; 1988 Nov; 34(14):1965-8. PubMed ID: 3204664 [Abstract] [Full Text] [Related]
3. Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432. Hanaue H, Nomoto S, Kimura T, Kutsuna T, Takeuchi T, Yoshizaki S. Keio J Med; 1982 Dec; 31(4):159-68. PubMed ID: 6985379 [No Abstract] [Full Text] [Related]
4. Clinical value of immunochemotherapy with OK-432 or PS-K for stomach cancer patients. Fujimoto S, Takahashi M, Minami T, Ishigami H, Miyazaki M, Itoh K. Jpn J Surg; 1979 Sep; 9(3):190-6. PubMed ID: 470251 [Abstract] [Full Text] [Related]
5. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)]. Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S. Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):997-1012. PubMed ID: 2202770 [Abstract] [Full Text] [Related]
6. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction. Katano M, Torisu M. Surgery; 1983 Mar 20; 93(3):365-73. PubMed ID: 6600854 [Abstract] [Full Text] [Related]
7. Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro. Uchida A, Hoshino T. Cancer; 1980 Feb 20; 45(3):476-83. PubMed ID: 6965464 [Abstract] [Full Text] [Related]
8. New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival. Torisu M, Katano M, Kimura Y, Itoh H, Takesue M. Surgery; 1983 Mar 20; 93(3):357-64. PubMed ID: 6187080 [No Abstract] [Full Text] [Related]
9. [Effect of PSK on cell-mediated immune status in the patients of stomach cancer]. Ogoshi K, Kondoh Y, Tajima T, Mitomi T. Gan To Kagaku Ryoho; 1983 Mar 20; 10(3):811-7. PubMed ID: 6411001 [Abstract] [Full Text] [Related]
10. [Administration of hemolytic streptococcus preparation OK-432 on recurrent gastric carcinoma]. Hanaue H, Kurosawa T, Kitano Y, Miyagawa S, Nemoto A, Yamato H, Asagoe T, Shikata J. Nihon Gan Chiryo Gakkai Shi; 1987 Aug 20; 22(7):1367-72. PubMed ID: 3501455 [No Abstract] [Full Text] [Related]
11. [Changes in nonspecific suppressor factors in the serum of gastric cancer patients after surgery and immunochemotherapy]. Nomoto K, Tsuru S, Awane Y, Kamei H, Ishibiki H, Sekiguchi M, Tamada R, Toge T, Nakajima T. Gan To Kagaku Ryoho; 1986 Mar 20; 13(3 Pt 1):458-63. PubMed ID: 3082287 [Abstract] [Full Text] [Related]
12. [Nonspecific cell-mediated immunity in gastric cancer patients - with special reference to immuno-reactivity of the regional lymph node and preoperative immunotherapy]. Takeshita M. Nihon Geka Gakkai Zasshi; 1983 Aug 20; 84(8):679-91. PubMed ID: 6610095 [Abstract] [Full Text] [Related]
13. [Non-specific immunotherapy with OK-432, streptococcus pyogenes preparation, for inoperable cancer patients of the digestive tract]. Hanaue H, Nomoto S, Yoshizaki S, Kitano Y, Miyakawa S, Horie F, Kurosawa T, Nemoto A, Yasuda H, Takada T. Nihon Gan Chiryo Gakkai Shi; 1984 Jul 20; 19(6):1307-14. PubMed ID: 6512346 [No Abstract] [Full Text] [Related]
15. [Evaluation of postoperative immunochemotherapy in lung cancer]. Ikeda T, Sakai T, Suito T, Kosaki G. Gan To Kagaku Ryoho; 1986 Apr 20; 13(4 Pt 1):1044-9. PubMed ID: 3008669 [Abstract] [Full Text] [Related]
16. [Influence of OK 432 upon postoperative alteration in activities producing lymphokines, IL 1, IL 2, and IFN, of peripheral blood mononuclear cells derived from patients with gastric cancer]. Hosoi J. Nihon Gan Chiryo Gakkai Shi; 1987 Apr 20; 22(3):603-13. PubMed ID: 2443588 [No Abstract] [Full Text] [Related]
17. Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparation. Hanaue H, Kim DY, Kubota M, Kurosawa T, Shikata J, Kondoh Y, Ogoshi K, Makuuchi H, Nakasaki H, Mitomi T. Tokai J Exp Clin Med; 1987 May 20; 12(2):97-102. PubMed ID: 3502432 [Abstract] [Full Text] [Related]
18. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer]. Yamane T, Sagara Y, Suzuki G, Kasuga M, Sakita M, Fujita Y, Majima S. Gan To Kagaku Ryoho; 1984 Apr 20; 11(4):930-4. PubMed ID: 6721507 [Abstract] [Full Text] [Related]
19. [The influence of a biological response modifier on thoracic lymphocytes--a study involving clinical cases and animal experiments]. Hanaue H, Kurosawa T, Miyakawa S, Kitano Y, Nemoto A, Yamoto H, Asagoe T, Shikata J. Gan To Kagaku Ryoho; 1986 Apr 20; 13(4 Pt 2):1285-9. PubMed ID: 3488025 [Abstract] [Full Text] [Related]